---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-032278"
form_type: "8-K"
ticker: "PALI"
cik: "0001357459"
company_name: "PALISADE BIO, INC."
filed_at: "2023-09-11T23:59:59+00:00"
generated_at: "2026-06-10T21:38:02.519008+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Palisade Bio appoints Mitchell Jones as CMO; grants inducement options and RSUs

## Summary
- Mitchell Jones, M.D., Ph.D., appointed Chief Medical Officer effective Sept 5, 2023.
- Herbert Slade ceased as CMO same date, will continue as consultant.
- Inducement grant: 75,000 options at $0.6897/share, 54,700 RSUs; vest over 3 years.
- Jones previously VP at Chemomab (CMMB), Finch Therapeutics (FNCH), Biora (BIOR); IBD expertise.
- Employment: base salary $415,000, target bonus 40%, severance provisions.

## SEC filing metadata
- accession: 0001493152-23-032278
- form_type: 8-K
- ticker: PALI
- cik: 0001357459
- company_name: PALISADE BIO, INC.
- filed_at: 2023-09-11T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 5.02, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1357459/000149315223032278/0001493152-23-032278-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1357459/000149315223032278/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-032278
- JSON: https://secwatch.observer/filing/0001493152-23-032278.json
- Plain text: https://secwatch.observer/filing/0001493152-23-032278.txt

## Key facts
- Executive change
  Mitchell Jones was appointed as Chief Medical Officer at PALISADE BIO, INC..
  - Action: appointed
  - Role: Chief Medical Officer
  source text: Mitchell Jones, M.D., Ph.D. (“Dr. Jones”) has been appointed Chief Medical Officer effective September 5, 2023
  evidence_url: https://www.sec.gov/Archives/edgar/data/1357459/000149315223032278/0001493152-23-032278-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.